BCSCDB: Biomarkers of Cancer Stem Cells Database
Number of entries related to UM-SCC-2 cell line is 43
| GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-22B | Cisplatin | FACs followed by SFA and Western Blotting | NA | 0.4 | 1 | 24709421 |
| CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-22B | Cisplatin | FACs and SFA | NA | 0.4 | 1 | 29121598 |
| CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-22B | NA | FACs followed by SFA | NA | 0.4 | 1 | 27780858 |
| CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-22B | Cisplatin | FACs followed by SFA | NA | 0.4 | 1 | 34689150 |
| CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-22B | Cisplatin | FACs | NA | 0.4 | 1 | 29861860 |
| CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-22B | NA | FACs followewd by SFA | NA | 0.4 | 1 | 22014666 |
| BMI1 | 1066 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-22A | Cisplatin | SFA followed by Western Blotting | NA | 0.28 | 0.1135 | 24709421 |
| BMI1 | 1066 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-22A | NA | Western Blotting followed by SFA | NA | 0.28 | 0.1135 | 34689150 |
| BMI1 | 1066 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-22A | Cisplatin | Western Blotting followed by SFA | NA | 0.28 | 0.1135 | 34689150 |
| BMI1 | 1066 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-22B | Cisplatin | SFA followed by Western Blotting | NA | 0.28 | 0.1135 | 24709421 |
| BMI1 | 1066 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-22B | NA | Western Blotting followed by SFA | NA | 0.28 | 0.1135 | 34689150 |
| BMI1 | 1066 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-22B | Cisplatin | Western Blotting followed by SFA | NA | 0.28 | 0.1135 | 34689150 |
| CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-22A | Cisplatin | SFA followed by Western Blotting | NA | 0.28 | 1 | 24709421 |
| CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-22A | Cisplatin | FACs followed by SFA | NA | 0.28 | 1 | 34689150 |
| CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-22A | NA | FACs | NA | 0.28 | 1 | 32066820 |
| CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-22A | NA | FACs followewd by SFA | NA | 0.28 | 1 | 22014666 |
| IL6R | 6019 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-22A | NA | Western Blotting followed by SFA | NA | 0.28 | 0.0021 | 34689150 |
| IL6R | 6019 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-22B | NA | Western Blotting followed by SFA | NA | 0.28 | 0.0021 | 34689150 |
| NANOG | 20857 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-22A | NA | Western Blotting | NA | 0.28 | 0.5461 | 25379016 |
| NANOG | 20857 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-22B | NA | Western Blotting | NA | 0.28 | 0.5461 | 25379016 |
| POU5F1 | 9221 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-22A | NA | Western Blotting | NA | 0.28 | 0.6448 | 25379016 |
| POU5F1 | 9221 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-22B | Cisplatin | SFA followed by Western Blotting | NA | 0.28 | 0.6448 | 24709421 |
| POU5F1 | 9221 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-22B | NA | Western Blotting | NA | 0.28 | 0.6448 | 25379016 |
| SOX2 | 11195 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-22A | NA | Western Blotting | NA | 0.28 | 0.5695 | 25379016 |
| SOX2 | 11195 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-22B | NA | Western Blotting | NA | 0.28 | 0.5695 | 25379016 |
| STAT3 | 11364 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-22A | NA | Western Blotting followed by SFA | NA | 0.28 | 0.0223 | 34689150 |
| STAT3 | 11364 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-22A | Cisplatin | Western Blotting followed by SFA | NA | 0.28 | 0.0223 | 34689150 |
| STAT3 | 11364 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-22B | NA | Western Blotting followed by SFA | NA | 0.28 | 0.0223 | 34689150 |
| STAT3 | 11364 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-22B | Cisplatin | Western Blotting followed by SFA | NA | 0.28 | 0.0223 | 34689150 |
| ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-2 | NA | ALDEFLUOR assay | NA | 0.12 | 0.684 | 24382806 |
| ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-22A | NA | ALDEFLUOR assay followed by SFA | NA | 0.12 | 0.684 | 34689150 |
| ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-22A | Cisplatin | FACs followed by SFA | NA | 0.12 | 0.684 | 34689150 |
| ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-22A | NA | FACs | NA | 0.12 | 0.684 | 32066820 |
| ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-22A | NA | FACs followewd by SFA | NA | 0.12 | 0.684 | 22014666 |
| ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-22B | Cisplatin | ALDEFLUOR assay and SFA | NA | 0.12 | 0.684 | 29121598 |
| ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-22B | Cisplatin | ALDEFLUOR assay followed by SFA | NA | 0.12 | 0.684 | 24709421 |
| ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-22B | NA | ALDEFLUOR assay followed by SFA | NA | 0.12 | 0.684 | 34689150 |
| ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-22B | NA | FACs followed by SFA | NA | 0.12 | 0.684 | 27780858 |
| ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-22B | Cisplatin | FACs followed by SFA | NA | 0.12 | 0.684 | 34689150 |
| ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-22B | Cisplatin | FACs | NA | 0.12 | 0.684 | 29861860 |
| ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-22B | NA | FACs followewd by SFA | NA | 0.12 | 0.684 | 22014666 |
| ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-29 | NA | ALDEFLUOR assay followed by SFA | NA | 0.12 | 0.684 | 23585151 |
| TPBG | 12004 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-22B | NA | FACs followed by SFA | NA | 0.12 | 0.0032 | 27780858 |